Michelle LeRoux Williams
Chief Tech/Sci/R&D Officer bij ELUTIA INC.
Vermogen: - $ op 31-03-2024
Profiel
Michelle LeRoux Williams is currently a member of the American Institute for Medical & Biological Engineering and the Chief Scientific Officer at Elutia, Inc. She was previously the Chief Scientific Officer at Osiris Therapeutics, Inc. from 2009 to 2014.
Dr. Williams holds a doctorate degree from Duke University and an undergraduate degree from Rice University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ELUTIA INC CLASS A
-.--% | 11-04-2024 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Michelle LeRoux Williams
| Bedrijven | Functie | Begin |
|---|---|---|
| ELUTIA INC. | Chief Tech/Sci/R&D Officer | 26-08-2022 |
American Institute For Medical & Biological Engineering
 American Institute For Medical & Biological Engineering Miscellaneous Commercial ServicesCommercial Services American Institute For Medical & Biological Engineering engages in research and development of medical and biological engineering. The private company is based in Washington. | Corporate Officer/Principal | - |
Eerdere bekende functies van Michelle LeRoux Williams
| Bedrijven | Functie | Einde |
|---|---|---|
| OSIRIS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 15-04-2014 |
Opleiding van Michelle LeRoux Williams
| Duke University | Doctorate Degree |
| Rice University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Osiris Therapeutics, Inc.
 Osiris Therapeutics, Inc. BiotechnologyHealth Technology Osiris Therapeutics, Inc. engages in the research, development, manufacture, and commercialization of regenerative medicine products. Its biosurgery business focuses on using unique tissue preservation technologies to develop viable human tissue products designed to improve wound closure and surgical outcomes for patients and physicians over standard of care alone. The company was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD. | Health Technology |
American Institute For Medical & Biological Engineering
American Institute For Medical & Biological Engineering Miscellaneous Commercial ServicesCommercial Services American Institute For Medical & Biological Engineering engages in research and development of medical and biological engineering. The private company is based in Washington. | Commercial Services |
| Elutia, Inc. |
